Journal
WORLD JOURNAL OF HEPATOLOGY
Volume 10, Issue 10, Pages 670-684Publisher
BAISHIDENG PUBLISHING GROUP INC
DOI: 10.4254/wjh.v10.i10.670
Keywords
Direct acting anti-viral agents; Hepatitis C virus infection; Post-liver transplant; Hepatitis C virus/human immunodeficiency virus co-infection
Categories
Ask authors/readers for more resources
Hepatitis C infection is universal and the most common indication of liver transplantation in the United States. The period of less effective interferon therapy with intolerable side effects has gone. Now we have stepped into the era of direct acting anti-viral agents (DAAs) against hepatitis C virus. Treatment of hepatitis C is now extremely effective, tolerable and requires a short duration of intake of oral agents. Less monitoring is required with the current therapy and drug-drug interactions are less than the previous regimen. The current treatment options of chronic hepatitis C with various DAAs are discussed in this article. (c) The Author(s) 2018. Published by Baishideng Publishing Group Inc. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available